Taylor Ben R

Officer · RXRX

As of 2026-09-27, Taylor Ben R has 31 Form 4 transactions on record across 1 company — 16 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $4.0MIndirect: $0$4.0Mas of 2026-09-27
  • Direct $4.0M
  • Indirect $0
RXRXdirect1,071,462 sh$4.0M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

RXRX · 31 trades
2026-09-15: Withheld for tax, 5,396 sh ($18K)2026-08-17: Withheld for tax, 25,018 sh ($79K)2026-06-15: Withheld for tax, 5,396 sh ($17K)2026-05-15: Withheld for tax, 25,018 sh ($76K)2026-04-06: Withheld for tax, 48,028 sh ($149K)2026-03-17: Sale, 7,956 sh ($27K)2026-03-16: Withheld for tax, 7,075 sh ($24K)2026-02-18: Sale, 13,426 sh ($41K)2026-02-17: Withheld for tax, 11,908 sh ($42K)2026-02-06: Withheld for tax, 11,400 sh ($45K)2026-02-06: Award / grant, 446,279 sh ($0)2026-02-06: Award / grant, 24,254 sh ($0)2025-12-29: Sale, 21,383 sh ($89K)2025-12-15: Withheld for tax, 7,057 sh ($31K)2025-11-25: Withheld for tax, 2,271 sh ($9K)2025-11-17: Withheld for tax, 11,908 sh ($49K)2025-09-15: Withheld for tax, 7,057 sh ($34K)2025-08-15: Withheld for tax, 11,908 sh ($67K)2025-06-16: Withheld for tax, 7,057 sh ($35K)2025-05-15: Withheld for tax, 11,908 sh ($51K)2025-04-01: Withheld for tax, 26,571 sh ($135K)2025-03-17: Withheld for tax, 7,057 sh ($48K)2025-02-18: Withheld for tax, 10,879 sh ($116K)2025-02-03: Withheld for tax, 6,544 sh ($47K)2025-02-03: Award / grant, 35,018 sh ($0)2025-02-03: Award / grant, 13,922 sh ($0)2025-02-03: Award / grant, 70,037 sh ($0)2024-12-19: Award / grant, 740,686 sh ($0)2024-12-19: Award / grant, 370,343 sh ($0)2024-12-17: Withheld for tax, 7,057 sh ($49K)2024-12-16: Withheld for tax, 15,668 sh ($95K)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-03-17RXRXSale7,956 @ $3.39$27K−0.7% of holding1,180,318Form 4
2026-02-18RXRXSale13,426 @ $3.08$41K−1.1% of holding1,195,349Form 4
2025-12-29RXRXSale21,383 @ $4.18$89K−2.7% of holding761,550Form 4
28 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-09-15RXRXWithheld for tax5,3961,071,462Form 4
2026-08-17RXRXWithheld for tax25,0181,076,858Form 4
2026-06-15RXRXWithheld for tax5,3961,101,876Form 4
2026-05-15RXRXWithheld for tax25,0181,107,272Form 4
2026-04-06RXRXWithheld for tax48,0281,132,290Form 4
2026-03-16RXRXWithheld for tax7,0751,188,274Form 4
2026-02-17RXRXWithheld for tax11,9081,208,775Form 4
2026-02-06RXRXWithheld for tax11,4001,220,683Form 4
2026-02-06RXRXAward / grant446,2791,207,829Form 4
2026-02-06RXRXAward / grant24,2541,232,083Form 4
2025-12-15RXRXWithheld for tax7,057782,933Form 4
2025-11-25RXRXWithheld for tax2,271789,990Form 4
2025-11-17RXRXWithheld for tax11,908792,261Form 4
2025-09-15RXRXWithheld for tax7,057804,169Form 4
2025-08-15RXRXWithheld for tax11,908811,226Form 4
2025-06-16RXRXWithheld for tax7,057823,134Form 4
2025-05-15RXRXWithheld for tax11,908830,191Form 4
2025-04-01RXRXWithheld for tax26,571842,099Form 4
2025-03-17RXRXWithheld for tax7,057868,670Form 4
2025-02-18RXRXWithheld for tax10,879875,727Form 4
2025-02-03RXRXWithheld for tax6,544886,606Form 4
2025-02-03RXRXAward / grant35,018879,228Form 4
2025-02-03RXRXAward / grant13,922893,150Form 4
2025-02-03RXRXAward / grant70,03770,037Form 4
2024-12-19RXRXAward / grant740,686740,686Form 4
2024-12-19RXRXAward / grant370,343844,210Form 4
2024-12-17RXRXWithheld for tax7,057473,867Form 4
2024-12-16RXRXWithheld for tax15,668480,924Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.